Discovery and Initial SAR of Arylsulfonylpiperazine Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)
Authors:
- Daqing SunDSDaqing Sun
- Juan C. JaenJJJuan C. Jaen
- Marc LabelleMLMarc Labelle
- Shichang MiaoSMShichang Miao
- 1 June 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (12) , 3513-3516
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: Novel therapeutic agents for the treatment of metabolic syndromeBioorganic & Medicinal Chemistry Letters, 2005
- Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1Bioorganic & Medicinal Chemistry Letters, 2005
- Perhydroquinolylbenzamides as Novel Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1Journal of Medicinal Chemistry, 2005
- Inhibition of 11?-HSD1 as a novel treatment for the metabolic syndrome: do glucocorticoids play a role?Expert Review of Cardiovascular Therapy, 2005
- 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in miceJournal of Experimental Medicine, 2005
- 11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone actionJournal of Endocrinology, 2005
- Synthesis and biological evaluation of sulfonamidooxazoles and β-keto sulfones: selective inhibitors of 11β-hydroxysteroid dehydrogenase type IBioorganic & Medicinal Chemistry Letters, 2005
- 11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid ResponseEndocrine Reviews, 2004
- Novel Adipose Tissue–Mediated Resistance to Diet-Induced Visceral Obesity in 11β-Hydroxysteroid Dehydrogenase Type 1–Deficient MiceDiabetes, 2004
- Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1Journal of Medicinal Chemistry, 2002